Brean Lifts PT on Inovio Pharma (INO) to $5; Expects Strong Data from VGX-3100 Phase 2

Go back to Brean Lifts PT on Inovio Pharma (INO) to $5; Expects Strong Data from VGX-3100 Phase 2
INOVIO PHARMACEUTICALS, Inc. (NASDAQ: INO) Delayed: 1.12 +0.03 (2.75%)
Previous Close $1.09    52 Week High $11.69 
Open $1.07    52 Week Low $4.50 
Day High $1.15    P/E N/A 
Day Low $1.04    EPS $-0.28 
Volume 4,289,259